The battle to provide obesity treatments jumps to a new level, with Eli Lilly announcing that an experimental drug that acts on three hormones (rather than the single target in Novo Nordisk’s Wegovy) led to substantial weight loss.
Welcome to VibeRide, home of the longboard brake. We’re group of guys from Salt Lake City who’s love of downhill skating sparked the idea for…
Welcome to VibeRide, home of the longboard brake. We’re group of guys from Salt Lake City who’s love of downhill skating sparked the idea for…
It is unclear whether the effect of canagliflozin on adverse kidney and cardiovascular events in those with diabetic kidney disease varies by age and sex.…
From body bags for rapid cooling to “prescriptions” for air conditioners, doctors are preparing for a future of extreme heat linked to climate change.
New research ties hearing aids to slower cognitive decline in those at higher risk of dementia.
Pharmaceutical giant Johnson & Johnson is the third drugmaker to sue the Biden administration over its new Medicare drug price negotiation program.
“GPT-4, being trained off of our own textual communication, shows the same — or maybe even more exaggerated — racial and sex biases as humans”…
The new Pfizer partnership with Flagship will fund the development of up to 10 drug candidates.
Join STAT for a discussion of what’s next for biosimilars, and what key signals will indicate how they might be prescribed, or paid for.
“Increasingly, I think patients, health insurers, providers and even investors are really saying, ‘How do we make sure digital health tools work, and what does…
